ArticleActa pharmaceutica Sinica. B2025

Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human study.

Wei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.